The New Immunoassay Analyser focused on Sensitivity & Time to First Result
EXPLORE THE DXI 9000 IMMUNOASSAY ANALYZER PEFORMANCE
EXPLORE WHAT'S UNIQUE
Click on picture
Beckman Coulter unveils the new DxI 9000 Access Immunoassay Analyzer, setting a new standard in performance and productivity for today’s busy labs with meaningful innovations that create time for you to focus on what matters most.
Zero Daily Maintenance Eliminate daily maintenance to amplify productivity less than 15 min. of cleaning per week
Precision Vision Technology - Learn more More automated safeguards than other systems available on the market today
Simple Solve Onboard Guide Has your back 24/7 with step-by-step instructions to keep things moving with less stress and more control
Beckman Coulter’s DxI 9000 Access Immunoassay Analyzer is designed to achieve faster throughput, employ an enhanced chemiluminescent substrate (Lumi-Phos PRO), deliver shorter turnaround times, run more tests per reagent pack, and provide improved user workflows,
Pathway to preparation plan.
What to expect before implementation
DxI 9000 Instrument Specifications
Data Sheet
Reimagine what’s possible with the DxI 9000
Immunoassay Analyzer to create time
Explore the DxI 9000 performance ! ZeroDaily Maintenance - PrecisionVision Technology: for real-time error detection & correction - Simple Solve Onboard Guide: helps fixes problems before they derail progress, putting control back in your hands. And more!
" With the DxI 9000, they have produced a machine that is faster, accurate, more reliable and this allows us to get the results back quicker to the patients and to the doctors for treatment" Listen to customers talk about their experience with the NEW DxI 9000.
Exceptional productivity in a compact design Reliability matters. This benchtop immunoassay analyzer fits labs with space constraints and delivers fast, reliable results. Learn more
ANNUAL TEST VOLUME >80,000 THROUGHPUT > 450 tests/hour
Immunoassay analyzers are used to identify and detect the concentration of specific substances in patient samples, usually using an antibody as a reagent. These devices are used in hospitals and clinical laboratories to perform a variety of tests including cancer, hormonology, serology, therapeutic drug monitoring and more. Beckman Coulter offers a variety of scalable immunoassay analyzers, which can help optimize your laboratory’s uptime, reliability and performance.
In general virus infection behavior, an IgM assay will give information about current or recent infection; while IgG will, in addition, also give information about a more sustainable immune response.These two pieces of the infection story blur together when the patient takes a combined, or total IgM and IgG test. Because seroconversion is such a highly individualized journey, separate SARS-CoV-2 IgM and IgG tests can provide greater insight into where the patient is at in their infection timeline